5IYENGAR S, WEBSTER AA, HEMRICK-LUECKE SK, et al. Efficacy of duloxetine, a potent and balanced serotonin-norepine- phrine inhibitor in persistent pain models in rats[J]. J Pharmacol Exp Ther, 2004, 311(2): 576-584.
6RABASSEDA X. Duloxetine-a new serotonin/noradrenaline reuptake inhibitor for the treatment of depression[J]. Drugs Today (Bare), 2004, 40 (9): 773-790.
7WONG DT, BYMASTER FP. Dual serotonin and noradrenaline uptake inhibitor class of antidepressants potential for greater efficacy or just hype?[J]. Prog Drug Res, 2002, 58 : 169-222.
8PERAHIA DG, PRITCHETT YL, DESAIAH D, et al. Efficacy of duloxetine in painful symptoms: an analgesic or antidepressant effect?[J]. Int Clin Psychopharmacol, 2006, 21 (6) : 311-317.
9RASKIN J, PRITCHETT YL, WANG F, et al. A double-blind, randomized muhicenter trial comparing duloxetine with placebo in the management of diabetic peripheral neuropathic pain [J]. Pain Med, 2005, 6(5) : 346-356.
10REN K, DUBNER R. Descending modulation in persistent pain : an update[J]. Pain, 2002, 100(1-2) : 1-6.
